股票/基金 实时行情 股吧

简称:冠昊生物 代码:300238


会计年度:2016-06-30收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
B型硬脑(脊)膜补片2,934,171.38571,183.572,362,987.8180.53
代理产品11,879,549.216,762,274.255,117,274.9643.08
合计102,389,362.2720,494,757.6181,894,604.6679.98
乳房补片109,425.2872,873.4836,551.8033.40
生物型硬脑(脊)膜补片78,009,464.676,259,742.9471,749,721.7391.98
无菌生物护创膜1,812,094.87713,982.821,098,112.0560.60
细胞技术服务4,371,915.254,927,016.76-555,101.51-12.70
胸普外科修补膜3,272,741.611,187,683.792,085,057.8263.71

会计年度:2015-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
医疗器械221,718,751.6236,167,654.91185,551,096.7183.69

会计年度:2015-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
B型硬脑(脊)膜补片2,750,167.73208,181.452,541,986.2892.43
代理产品2,735,581.211,738,283.66997,297.5536.46
合计85,767,975.2311,164,729.3274,603,245.9186.98
脑膜建—生物型硬脑(脊)膜补片74,951,151.496,039,836.4768,911,315.0291.94
无菌生物护创膜1,370,558.69574,215.33796,343.3658.10
细胞技术服务1,403,652.111,981,462.38-577,810.27-41.16
胸普外科修补膜2,556,864.00622,750.031,934,113.9775.64

会计年度:2014-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
医疗器械189,251,438.1221,753,444.06167,497,994.0688.51

会计年度:2014-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
B型硬脑(脊)膜补片1,877,464.1487,659.471,789,804.6795.33
北大区17,884,735.181,138,506.1516,746,229.0393.63
代理产品805,213.70669,820.43135,393.2716.81
东大区37,677,642.243,971,570.3433,706,071.9089.46
合 计79,054,169.718,955,678.7670,098,490.9588.67
合计79,054,169.718,955,678.7670,098,490.9588.67
南大区7,860,923.411,727,665.206,133,258.2178.02
脑膜建—生物型硬脑(脊)膜补片69,066,227.126,564,268.9462,501,958.1890.50
无菌生物护创膜4,543,318.391,083,435.953,459,882.4476.15
西大区15,630,868.882,117,937.0713,512,931.8186.45
细胞技术服务75,471.70116,427.05-40,955.35-54.27
胸普外科修补膜2,686,474.66434,066.922,252,407.7483.84
医疗器械79,054,169.718,955,678.7670,098,490.9588.67

    3/5 转到